Bifidobacterium lactis in Treatment of Children with Acute Diarrhea. A Randomized Double Blind Controlled Trial
DOI:
https://doi.org/10.3889/oamjms.2015.088Keywords:
probiotics, Bifidobacterium lactis, acute diarrhea, childrenAbstract
BACKGROUND: Probiotics are becoming increasingly popular treatment for children diarrhea. Although there are several probiotic strains potentially useful, researches were often limited to certain strains.
AIM: To test Bifidobacterium lactis on morbidity of acute diarrhea in children less than 2 years.
SUBJECTS AND METHODS: A randomized double-blind controlled clinical trial was conducted in 50 children (1 - 23 months) admitted with acute diarrhea to the Pediatric Hospital, Cairo University and were randomly assigned to receive in addition to usual treatment of diarrhea according to WHO guidelines; one of two treatments either milk formula non-supplemented (n = 25) or supplemented (n = 25) with Bifidobacterium lactis 14.5 x 106 CFU/100 ml daily for one week. Primary outcomes were frequency and duration of diarrhea and hospital stay. Secondary outcomes were duration of fever and vomiting episodes. Safety and tolerance were also recorded.
RESULTS: On admission, patients’ characteristics of both groups (50 cases) were similar. For children who received the probiotics for one week; mean duration of diarrhoea was shorter than in controls (3.12 ± 0.92 vs. 4.10 ± 0.94 days) (P = 0.02), number of motions per day was less than in controls (3.96 ± 0.62 vs. 4.46 ± 0.85) (P = 0.04) and discharge from hospital <2 days was more frequent than in controls (72% vs. 44%) (P = 0.048). There was no effect on fever (P = 0.63) or vomiting (P = 0.54).
CONCLUSION: Bifidobacterium lactis probiotics in supplemented milk formula decreased significantly frequency, duration of diarrhea, and hospital stay than usual treatment alone in children with acute diarrhea. Additional researches on other uncommon local probiotic species should be encouraged.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in Gastrointestinal Diseases in Children: Hard and Not-So-Hard Evidence of Efficacy. Journal of Pediatric Gastroenterology and Nutrition. 2006;42:454-475. DOI: https://doi.org/10.1097/01.mpg.0000221913.88511.72
Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002.
Hempel S. Probiotics for diarrhoea. Indian J Med Res. 2014;139: 339-341.
Fijan S. Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature. Int J Environ Res Public Health. 2014; 11: 4745-4767. DOI: https://doi.org/10.3390/ijerph110504745
Aggarwal S, Upadhyay A, Shah D, Teotia N, Agarwal A, Jaiswal V. Lactobacillus GG for treatment of acute childhood diarrhoea: An open labelled, randomized controlled trial. Indian J Med Res. 2014; 139: 379-385.
Applegate JA, Walker CLF, Ambikapathi R, Black RE. Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children. BMC Public Health. 2013; 13(Suppl 3):S16. DOI: https://doi.org/10.1186/1471-2458-13-S3-S16
Aggarwal S, Upadhyay A, Shah D, Teotia N, Agarwal A, Jaiswal V. Lactobacillus GG for treatment of acute childhood diarrhoea: An open-labelled randomized controlled trial. Indian J Med Res. 2014; 139 : 379-85.
Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther. 2011;34(9):1079-87. DOI: https://doi.org/10.1111/j.1365-2036.2011.04837.x
de Vrese M, Kristen H, Rautenberg P, Laue C, Schrezenmeir J. Probiotic lactobacilli and bifidobacteria in a fermented milk product with added fruit preparation reduce antibiotic associated diarrhea and Helicobacter pylori activity. J Dairy Res. 2011;78(4):396-403. DOI: https://doi.org/10.1017/S002202991100063X
Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011;45 (Suppl):S149-53. DOI: https://doi.org/10.1097/MCG.0b013e3182257e98
Ciccarelli S, Stolfi I, Caramia G. Management strategies in the treatment of neonatal and pediatric gastroenteritis. Infect Drug Resist. 2013;6:133–161. DOI: https://doi.org/10.2147/IDR.S12718
Phavichitr N, Puwdee P, Tantibhaedhyangkul R. Cost-benefit analysis of the probiotic treatment of children hospitalized for acute diarrhea in Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2013;44: 1065–1071.
Wu ZJ, Du X, Zheng J. Role of Lactobacillus in the prevention of Clostridium difficile-associated diarrhea: A meta-analysis of randomized controlled trials. Chin Med J (Engl). 2013;126:4154–4161.
Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R. Meta-analysis:Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes. 2014; 5(3):285-93.
Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Paediatr Drugs. 2005;7(2):111-22. DOI: https://doi.org/10.2165/00148581-200507020-00004
Yu H, Liu L, Chang Z, Wang S, Wen B, Yin P, Liu D, Chen B, Zhang J. Genome Sequence of the Bacterium Bifidobacterium longum Strain CMCC P0001, a Probiotic Strain Used for Treating Gastrointestinal Disease. Genome Announc. 2013;1(5). pii: e00716-13. DOI: https://doi.org/10.1128/genomeA.00716-13
Shan LS, Hou P, Wang ZJ, Liu FR, Chen N, Shu LH, Zhang H, Han XH, Han XX, Cai XX, et al. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes. 2013;1: 329–334. DOI: https://doi.org/10.3920/BM2013.0008
Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics for the prevention and treatment of antibiotic- associated diarrhea: A systematic review and meta-analysis. JAMA. 2012; 307: 1959–1969. DOI: https://doi.org/10.1001/jama.2012.3507
Corcionivoschi N, Drinceanu d, Stef L, Luca I, Julean C, Mingyart O. Probiotics – identification and ways of action. Innovative Romanian Food Biotechnology. 2010; 6: 1-11.
Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004;38(3):288-92. DOI: https://doi.org/10.1097/00005176-200403000-00011
World Health Organization (WHO). The treatment of diarrhoea: a manual for physicians and other senior health workers - 4th rev. Geneva: WHO 2005; WHO/COD/SER/80.2, 2005.
Friedman JN, Goldman RD, Srivastava R, Parkin PC. Development of a clinical dehydration scale for use in children between 1 and 36 months of age. J Pediatr. 2004;145 (2):201–207. DOI: https://doi.org/10.1016/j.jpeds.2004.05.035
Chen J, Cai W, Feng Y. Development of intestinal bifidobacteria and Lactobacilli in breast-fed neonates. Clin Nutr. 2007; 26: 559–566. DOI: https://doi.org/10.1016/j.clnu.2007.03.003
Noriega L, Cuevas I, Margolles A, de los Reyes-Gavilán CG. Deconjugation and bile salts hydrolase activity by Bifidobacterium strains with acquired resistance to bile. Int Dairy J. 2006;16: 850–855. DOI: https://doi.org/10.1016/j.idairyj.2005.09.008
Hemaiswarya S, Raja R, Ravikumar R, Isabel SC. Mechanism of Action of Probiotics. Brazilian archives of Biology and technology. 2013;56(1): 113-119. DOI: https://doi.org/10.1590/S1516-89132013000100015
Jungersen M, Wind A, Johansen E, Christensen JE, Stuer-Lauridsen B., Eskesen D. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12. Microorganisms 2014;2:92-110. DOI: https://doi.org/10.3390/microorganisms2020092
Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;CD003048.
Szajewska H, Sko´rka A, Ruszczyn´ski M, et al. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children—updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013;38: 467–76. DOI: https://doi.org/10.1111/apt.12403
Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;CD003048. DOI: https://doi.org/10.1002/14651858.CD003048.pub3
Szajewska H, Urbańska M, Chmielewska A, Weizman Z, Shamir R. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes. 2014;5(3):285-93. DOI: https://doi.org/10.3920/BM2013.0056
Mao M, Yu T, Xiong Y, et al. Effect of a lactose-free milk formula supplemented with bifidobacteria and streptococci on the recovery from acute diarrhoea. Asia Pac J Clin Nutr. 2008;17:30–4.
Petschow B, Figueroa R, Harris C, et al. Comparison of intestinal colonization and tolerance following oral administration of different levels of Lactobacillus rhamnosus strain GG (LGG) in healthy term infants [abstract]. J Pediatr Gastroenterol Nutr. 2003;36:566.
Matarese LE, Seidner DL, Steiger E. The role of probiotics in gastrointestinal disease. Nutr Clin Pract. 2003;18:507–516. DOI: https://doi.org/10.1177/0115426503018006507
Isolauri E, Ribeiro HC, Gibson G, et al. Functional foods and probiotics: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35: S106–S109. DOI: https://doi.org/10.1097/00005176-200208002-00007
Kailam M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Pediatr Res. 1992;32:141–144. DOI: https://doi.org/10.1203/00006450-199208000-00002
Shu Q, Qu F, Gill H.S. Probiotic Treatment Using Bifidobacterium lactis HN019 Reduces Weanling Diarrhea Associated With Rotavirus and Escherichia coli Infection in a Piglet Mode. Journal of Pediatric Gastroenterology and Nutrition. 2001;33:171–177. DOI: https://doi.org/10.1097/00005176-200108000-00014
Correa NB, Peret Filho LA, Penna FJ. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. J Clin Gastroenterol. 2005;39: 385Y9. DOI: https://doi.org/10.1097/01.mcg.0000159217.47419.5b
Alsheikh A, Weizman Z. Safety of infant formula supplemented with two strains of probiotics in early infancy [abstract]. Pediatr Res. 2003;53:174A. DOI: https://doi.org/10.1016/S0261-5614(03)80259-5
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
